MS4A5
gene geneOn this page
Also known as CD20L2
Summary
MS4A5 (membrane spanning 4-domains A5, HGNC:13374) is a protein-coding gene on chromosome 11q12.2, encoding Membrane-spanning 4-domains subfamily A member 5 (Q9H3V2). May be involved in signal transduction as a component of a multimeric receptor complex.
This gene encodes a member of the membrane-spanning 4A gene family. Members of this nascent protein family are characterized by common structural features and similar intron/exon splice boundaries and display unique expression patterns among hematopoietic cells and nonlymphoid tissues. Though this member is not expressed in hematopoietic cells specifically, it may be involved in signal transduction like many of its related family members. The gene encoding this protein is localized to 11q12, among a cluster of family members.
Source: NCBI Gene 64232 — RefSeq curated summary.
At a glance
- GWAS associations: 1
- Clinical variants (ClinVar): 26 total
- MANE Select transcript:
NM_023945
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:13374 |
| Approved symbol | MS4A5 |
| Name | membrane spanning 4-domains A5 |
| Location | 11q12.2 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | CD20L2 |
| Ensembl gene | ENSG00000166930 |
| Ensembl biotype | protein_coding |
| OMIM | 606499 |
| Entrez | 64232 |
Gene structure
Transcript identifiers
Ensembl transcripts: 6 — 3 protein_coding, 2 nonsense_mediated_decay, 1 protein_coding_CDS_not_defined
ENST00000300190, ENST00000528093, ENST00000528905, ENST00000531403, ENST00000533885, ENST00000534071
RefSeq mRNA: 1 — MANE Select: NM_023945
NM_023945
CCDS: CCDS7987
Canonical transcript exons
ENST00000300190 — 5 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001107902 | 60429572 | 60429827 |
| ENSE00001107903 | 60433765 | 60433917 |
| ENSE00001107907 | 60430796 | 60430924 |
| ENSE00003591100 | 60447649 | 60447792 |
| ENSE00003687229 | 60432411 | 60432467 |
Expression profiles
Bgee: expression breadth broad, 98 present calls, max score 97.47.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.0751 / max 90.2170, expressed in 4 samples.
FANTOM5 promoters (2 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 114470 | 0.0421 | 4 |
| 114471 | 0.0330 | 3 |
Top tissues by expression
248 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| sperm | CL:0000019 | 97.47 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 95.65 | gold quality |
| male germ cell | CL:0000015 | 95.52 | gold quality |
| left testis | UBERON:0004533 | 91.81 | gold quality |
| right testis | UBERON:0004534 | 90.97 | gold quality |
| testis | UBERON:0000473 | 88.82 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 88.20 | gold quality |
| buccal mucosa cell | CL:0002336 | 84.79 | gold quality |
| adult organism | UBERON:0007023 | 78.46 | gold quality |
| tongue squamous epithelium | UBERON:0006919 | 63.11 | gold quality |
| olfactory bulb | UBERON:0002264 | 60.47 | gold quality |
| type B pancreatic cell | CL:0000169 | 60.26 | gold quality |
| diaphragm | UBERON:0001103 | 56.18 | gold quality |
| kidney epithelium | UBERON:0004819 | 53.01 | gold quality |
| thymus | UBERON:0002370 | 50.86 | gold quality |
| epithelial cell of pancreas | CL:0000083 | 50.31 | gold quality |
| quadriceps femoris | UBERON:0001377 | 49.98 | gold quality |
| hair follicle | UBERON:0002073 | 49.98 | gold quality |
| Brodmann (1909) area 46 | UBERON:0006483 | 49.78 | gold quality |
| cervix squamous epithelium | UBERON:0006922 | 49.20 | gold quality |
| vastus lateralis | UBERON:0001379 | 48.93 | gold quality |
| oviduct epithelium | UBERON:0004804 | 48.88 | gold quality |
| myocardium | UBERON:0002349 | 48.87 | gold quality |
| cerebellar vermis | UBERON:0004720 | 48.63 | gold quality |
| cardiac muscle of right atrium | UBERON:0003379 | 48.55 | gold quality |
| CA1 field of hippocampus | UBERON:0003881 | 48.50 | gold quality |
| oocyte | CL:0000023 | 48.39 | gold quality |
| cervix epithelium | UBERON:0004801 | 48.39 | gold quality |
| left ventricle myocardium | UBERON:0006566 | 48.24 | gold quality |
| orbitofrontal cortex | UBERON:0004167 | 48.20 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 2.93 |
Regulation
Is transcription factor: no
Cross-species orthologs
26 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | ms4a17a.6 | ENSDARG00000007018 |
| danio_rerio | ms4a17a.4 | ENSDARG00000014024 |
| danio_rerio | si:dkey-77f5.10 | ENSDARG00000020548 |
| danio_rerio | zgc:113425 | ENSDARG00000026616 |
| danio_rerio | ms4a17c.2 | ENSDARG00000028659 |
| danio_rerio | ms4a17a.7 | ENSDARG00000043796 |
| danio_rerio | ms4a17a.1 | ENSDARG00000043798 |
| danio_rerio | ms4a17a.8 | ENSDARG00000043802 |
| danio_rerio | ms4a17a.12 | ENSDARG00000053563 |
| danio_rerio | ms4a17a.16 | ENSDARG00000054898 |
| danio_rerio | si:dkey-7j14.6 | ENSDARG00000090552 |
| danio_rerio | ms4a17a.3 | ENSDARG00000091970 |
| danio_rerio | ms4a17a.5 | ENSDARG00000092204 |
| danio_rerio | si:dkey-174k12.3 | ENSDARG00000092593 |
| danio_rerio | si:dkey-238j22.1 | ENSDARG00000093512 |
| danio_rerio | si:ch73-56d11.5 | ENSDARG00000093546 |
| danio_rerio | ms4a17c.1 | ENSDARG00000094643 |
| danio_rerio | ms4a17a.11 | ENSDARG00000094809 |
| danio_rerio | ms4a17a.9 | ENSDARG00000094854 |
| danio_rerio | ms4a17a.10 | ENSDARG00000095695 |
| danio_rerio | si:ch73-56d11.3 | ENSDARG00000097527 |
| danio_rerio | tmem176l.3a | ENSDARG00000098387 |
| danio_rerio | ms4a17a.2 | ENSDARG00000105674 |
| danio_rerio | ms4a17a.17 | ENSDARG00000116378 |
| mus_musculus | Ms4a5 | ENSMUSG00000054523 |
| rattus_norvegicus | Ms4a5 | ENSRNOG00000025857 |
Paralogs (16): MS4A12 (ENSG00000071203), MS4A6A (ENSG00000110077), MS4A4A (ENSG00000110079), MS4A3 (ENSG00000149516), MS4A2 (ENSG00000149534), MS4A1 (ENSG00000156738), MS4A6E (ENSG00000166926), MS4A7 (ENSG00000166927), MS4A14 (ENSG00000166928), MS4A8 (ENSG00000166959), MS4A15 (ENSG00000166961), MS4A10 (ENSG00000172689), TMEM212 (ENSG00000186329), MS4A13 (ENSG00000204979), MS4A18 (ENSG00000214782), MS4A4E (ENSG00000214787)
Protein
Protein identifiers
Membrane-spanning 4-domains subfamily A member 5 — Q9H3V2 (reviewed: Q9H3V2)
Alternative names: CD20 antigen-like 2, Testis-expressed transmembrane protein 4
All UniProt accessions (5): Q9H3V2, A0A0B4J228, E9PKT5, H0YD29, H0YDK1
UniProt curated annotations — full annotation on UniProt →
Function. May be involved in signal transduction as a component of a multimeric receptor complex.
Subcellular location. Membrane.
Tissue specificity. Expressed at high level in the testis. Detected also in the pancreas, heart and in the brain.
Similarity. Belongs to the MS4A family.
RefSeq proteins (1): NP_076434* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR007237 | CD20-like_TM | Domain |
| IPR030417 | MS4A | Family |
Pfam: PF04103
UniProt features (12 total): topological domain 5, transmembrane region 4, chain 1, sequence variant 1, sequence conflict 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q9H3V2-F1 | 75.96 | 0.42 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 21 (showing top):
GNF2_CCNA1, WEBER_METHYLATED_LCP_IN_SPERM_UP, MODULE_48, MODULE_95, TEF_Q6, MODULE_163, BRCA1_DN.V1_DN, GSE1460_INTRATHYMIC_T_PROGENITOR_VS_DP_THYMOCYTE_UP, WEBER_METHYLATED_LCP_IN_FIBROBLAST_UP, GSE37416_CTRL_VS_0H_F_TULARENSIS_LVS_NEUTROPHIL_UP, GSE3982_EOSINOPHIL_VS_MAST_CELL_UP, GSE3982_MAST_CELL_VS_BASOPHIL_DN, GSE3982_BCELL_VS_BASOPHIL_DN, GSE6269_E_COLI_VS_STREP_PNEUMO_INF_PBMC_UP, chr11q12
GO Biological Process (1): cell surface receptor signaling pathway (GO:0007166)
GO Molecular Function (0):
GO Cellular Component (2): plasma membrane (GO:0005886), membrane (GO:0016020)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| signal transduction | 1 |
| membrane | 1 |
| cell periphery | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
192 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| MS4A5 | MS4A2 | Q01362 | 858 |
| MS4A5 | OOSP4B | A0A2R8Y4Y8 | 695 |
| MS4A5 | TMEM176A | Q96HP8 | 597 |
| MS4A5 | MS4A6E | Q96DS6 | 584 |
| MS4A5 | OOSP2 | Q86WS3 | 550 |
| MS4A5 | GARIN2 | Q8N9W8 | 549 |
| MS4A5 | MS4A18 | Q3C1V0 | 532 |
| MS4A5 | MS4A12 | Q9NXJ0 | 478 |
| MS4A5 | MS4A15 | Q8N5U1 | 474 |
| MS4A5 | MS4A4E | Q96PG1 | 473 |
| MS4A5 | SVBP | Q8N300 | 460 |
| MS4A5 | MS4A1 | P08984 | 459 |
| MS4A5 | TMEM86B | Q8N661 | 452 |
| MS4A5 | LRRC36 | Q1X8D7 | 435 |
| MS4A5 | ATP10D | Q9P241 | 428 |
IntAct
2 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| CFTR | psi-mi:“MI:0914”(association) | 0.350 |
BioGRID (1): MS4A5 (Affinity Capture-MS)
ESM2 similar proteins: A0A2R8RY99, A4IIV4, A8MUP6, A9UL59, B2RVW2, C9JDP6, E9Q6I0, H7C241, O95859, P0DP42, P56749, Q0IIL2, Q0V9E0, Q29RH7, Q2KHT4, Q32KQ5, Q3SZT1, Q3T110, Q3UUA0, Q4V922, Q5CZV0, Q5FWC3, Q5J8X5, Q5R8B5, Q5R9K1, Q6AXT9, Q6AYL2, Q6GV27, Q6GV28, Q6ICI0, Q7T392, Q80SV1, Q80WE5, Q86WI0, Q8CJ58, Q8K445, Q8NHS1, Q8R1W2, Q8VI88, Q96CE8
Diamond homologs: A6QPF4, P11836, P13386, P19437, P20490, Q01362, Q3C1V0, Q3C2E2, Q3UPL6, Q8N5U1, Q920C4, Q96JA4, Q96JQ5, Q99N05, Q99N07, Q99N09, Q99N10, Q9BY19, Q9H2W1, Q9H3V2, Q9NXJ0, Q5REZ6, Q96HJ5, Q96PG2, Q99N08, Q9GZW8, Q96PG1, Q96DS6
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
26 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 24 |
| Likely benign | 2 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
567 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 11:60429825:GGG:G | donor_gain | 0.9900 |
| 11:60429826:GGG:G | donor_gain | 0.9900 |
| 11:60432409:A:AG | acceptor_gain | 0.9900 |
| 11:60432410:G:GG | acceptor_gain | 0.9900 |
| 11:60429826:GG:G | donor_gain | 0.9800 |
| 11:60429826:GGGTA:G | donor_loss | 0.9800 |
| 11:60429827:GG:G | donor_gain | 0.9800 |
| 11:60429827:GGTA:G | donor_loss | 0.9800 |
| 11:60429828:G:GG | donor_gain | 0.9800 |
| 11:60429828:GTAA:G | donor_loss | 0.9800 |
| 11:60432410:GTTC:G | acceptor_gain | 0.9800 |
| 11:60429830:A:AG | donor_loss | 0.9600 |
| 11:60432410:GTTCA:G | acceptor_gain | 0.9500 |
| 11:60429832:G:GG | donor_gain | 0.9300 |
| 11:60432410:GTT:G | acceptor_gain | 0.9300 |
| 11:60432464:TCTGG:T | donor_loss | 0.9300 |
| 11:60432466:TGGTG:T | donor_loss | 0.9300 |
| 11:60432467:GGTGA:G | donor_loss | 0.9300 |
| 11:60432468:G:GG | donor_gain | 0.9300 |
| 11:60432469:TGA:T | donor_loss | 0.9300 |
| 11:60432470:GAGT:G | donor_loss | 0.9300 |
| 11:60432471:A:AT | donor_loss | 0.9300 |
| 11:60432472:G:A | donor_loss | 0.9300 |
| 11:60433672:C:G | donor_gain | 0.9300 |
| 11:60433890:GT:G | donor_gain | 0.9300 |
| 11:60429823:TAGGG:T | donor_gain | 0.9200 |
| 11:60429824:AGGG:A | donor_gain | 0.9200 |
| 11:60429825:GGGG:G | donor_gain | 0.9200 |
| 11:60429831:A:AG | donor_gain | 0.9100 |
| 11:60433655:GCAT:G | donor_gain | 0.9000 |
AlphaMissense
1305 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 11:60433795:A:C | S124R | 0.991 |
| 11:60433797:T:A | S124R | 0.991 |
| 11:60433797:T:G | S124R | 0.991 |
| 11:60430910:T:A | W90R | 0.987 |
| 11:60430910:T:C | W90R | 0.987 |
| 11:60430815:G:A | G58E | 0.985 |
| 11:60432411:T:C | F95L | 0.982 |
| 11:60432413:C:A | F95L | 0.982 |
| 11:60432413:C:G | F95L | 0.982 |
| 11:60430887:T:A | I82K | 0.978 |
| 11:60430901:T:G | Y87D | 0.978 |
| 11:60433816:G:A | G131R | 0.977 |
| 11:60433816:G:C | G131R | 0.977 |
| 11:60430814:G:A | G58R | 0.976 |
| 11:60430814:G:C | G58R | 0.976 |
| 11:60447676:A:C | S174R | 0.976 |
| 11:60447678:C:A | S174R | 0.976 |
| 11:60447678:C:G | S174R | 0.976 |
| 11:60430835:G:A | G65R | 0.975 |
| 11:60430835:G:C | G65R | 0.975 |
| 11:60430836:G:A | G65E | 0.975 |
| 11:60433864:T:A | C147S | 0.973 |
| 11:60433865:G:C | C147S | 0.973 |
| 11:60433788:T:A | N121K | 0.972 |
| 11:60433788:T:G | N121K | 0.972 |
| 11:60432424:G:A | G99E | 0.971 |
| 11:60430913:G:C | G91R | 0.969 |
| 11:60430899:G:A | G86E | 0.967 |
| 11:60433804:G:A | G127R | 0.966 |
| 11:60433804:G:C | G127R | 0.966 |
dbSNP variants (sampled 300 via entrez): RS1000044168 (11:60428472 T>C), RS1000136976 (11:60444395 C>T), RS1000352963 (11:60428737 G>C), RS1000742442 (11:60443191 G>A,T), RS1000864143 (11:60448036 GT>G), RS1000884882 (11:60436705 GA>G), RS1001026844 (11:60443441 T>C), RS1001153928 (11:60430828 T>C,G), RS1001177489 (11:60427652 A>G), RS1001208550 (11:60428085 A>G), RS1001411916 (11:60444288 C>A,T), RS1001412934 (11:60433640 C>G), RS1001546583 (11:60437202 C>G,T), RS1001894472 (11:60441438 G>A), RS1001928555 (11:60447989 A>G)
Disease associations
OMIM: gene MIM:606499 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
1 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST007471_3 | Short-term memory (digit-span task) | 1.000000e-06 |
EFO canonical traits (1, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0004335 | short-term memory |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
8 total (human), top 8 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| bisphenol A | affects cotreatment, increases methylation | 1 |
| theaflavin-3,3’-digallate | affects expression | 1 |
| Fulvestrant | affects cotreatment, increases methylation | 1 |
| Benzo(a)pyrene | affects methylation | 1 |
| Cadmium | decreases expression, increases abundance | 1 |
| Tretinoin | decreases expression | 1 |
| Aflatoxin B1 | decreases methylation | 1 |
| Cadmium Chloride | decreases expression, increases abundance | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.